The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Order Print Edition

This publication discusses the use of Freelite (serum free light chain assay) and Hevylite (serum heavy/light chain assay) tests for monitoring myeloma.
This publication discusses the option of autologous stem cell transplant (ASCT) for the treatment of myeloma.
This publication discusses the use of Kyprolis (carfilzomib)— a proteasome inhibitor—for the treatment of myeloma.
This publication covers monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
This publication discusses the use of Ninloro (ixazomb)—a proteasome inhibitor—for the treatment of myeloma.
This publication discusses peripheral neuropathy, which can be a complication of multiple myeloma or its treatments.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt out, click for more information.